Open AccessDetection of Chlamydia trachomatis and Neisseria gonorrhoeae in Swab Specimens by the Hybrid Capture II and PACE 2 Nucleic Acid Probe Tests
Author(s) -
Kevin J. Modarress,
Allison P. Cullen,
William J. Jaffurs,
Gerald Troutman,
Narjes Mousavi,
Roger A. Hubbard,
Susan Henderson,
Attila T. Lörincz
Publication year - 1999
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/00007435-199905000-00012
Subject(s) - neisseria gonorrhoeae , chlamydia trachomatis , chlamydiales , medicine , chlamydiaceae , sexually transmitted disease , nucleic acid amplification tests , gonorrhea , virology , chlamydia , microbiology and biotechnology , biology , immunology , syphilis , human immunodeficiency virus (hiv)
The Digene Hybrid Capture II (HC II) CT/GC Test (Digene Corp., Beltsville, MD) is a new nucleic acid signal amplification-based test for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in specimens from the genital tract. For optimal results, the HC II CT/GC Test employs a special conical shaped brush for cervical specimen collection from nonpregnant women and swabs from pregnant women.